Foundation for Medical Research Publications

  1. Ambrose EJ, Khanolkar SR, Antia NH,   Chulawalla RG, Koticha KK. Rapid test for drug resistance in leprosy. Lancet, 1977, 2: 1036.
  2. Antia NH. Radioisotope labeling of M. leprae.  Insd J Lepr, 1978, 50: 123-125.
  3. Ambrose EJ, Khanolkar SR, Chulawalla RG. A rapid test for bacillary resistance to dapsone. Ind J Lepr, 1978, 50: 131-143.
  4. Khanolkar SR, Ambrose EJ, Chulawalla RG, Bapat CV. Auto radiographic  and  metabolic studies of  M. leprae.  Lep Rev, 1978, 49: 187-198.
  5. Birdi TJ, Salgame PR, Antia NH. The role of macrophages in leprosy as studied by protein synthesis of macrophages from resistant and susceptible hosts - A mouse and human study. Ind.   Ind J Lep, 1979, 23-42.
  6. Antia NH. Study of the evolution of nerve damage in leprosy: A general introduction. Ind J Lepr, 1980, 52: 3-4.
  7. Shetty VP, Mehta LN, Irani PF, Antia NH. Study of the evolution of nerve damage in leprosy: Part I - Observations on the index branch of the radial cutaneous nerve in contacts of leprosy. Ind J Lepr, 1980, 52: 19-25.
  8. Shetty VP, Mehta LN, Irani PF, Antia NH. Study of the evolution of nerve damage in leprosy: Part II - Observations on the index branch of the radial cutaneous nerve in contacts of leprosy. Ind J Lepr, 1980, 52: 19-25.
  9. Shetty VP, Vidyasagar PB, Antia NH. Study of the evolution of nerve damage in leprosy. Part III - Sciatic nerve lesions in mice inoculated with M. leprae with nerve   conduction velocity correlates. Ind J Lepr, 1980, 50: 26-47.
  10. Antia NH, Shetty VP, Mehta LN. Study of the evolution of nerve damage in leprosy. Part IV - An assessment. Ind J Lepr, 1980, 52: 48-52.
  11. Salgame PR, Birdi TJ, Mahadevan PR, Antia NH. Role of macrophages in defective cell mediated immunity in lepromatous leprosy Factor(s) from macrophages affecting protein synthesis and lymphocyte transformation. Int J Lepr, 1980, 48: 172-177.
  12. Birdi TJ, Salgame PR, Mahadevan PR, Antia NH. Role of macrophages in defective cell mediated immunity in lepromatous leprosy. II - Macrophage and lymphocyte interaction. Int J Lepr, 1980, 48: 178-182.
  13. Shetty VP, Antia NH. Myelination around multiple axons in the peripheral nerve: An unusual ultrastructural observation. Acta Neuropathol, 1980, 50: 147-151.
  14. Mukherjee R, Mahadevan PR, Antia NH. Organized nerve culture.  I - A technique to study the effect of M. leprae infection. Int J Lepr, 1980, 48: 183-188.
  15. Mukherjee R, Mahadevan PR, Antia NH. Organised nerve culture II - DNA synthesis in Schwann cells in the presence of M. leprae. Int J Lepr, 1980, 48: 189-192.
  16. Mahadevan PR, Antia NH. Biochemical alteration in cells following phagocytosis of M.leprae - The consequence - A basic concept. Int J Lepr, 1980, 48: 167-171.
  17. Jayaraman P, Mahadevan PR, Mester M and Mester L. Inhibition of the incorporation of (3H) DOPA M.leprae by desoxyfructo-serotonin. Biochem Pharmacol, 1980, 29: 2526-2528.
  18. Young, DB. Identification of M. leprae: Use of wall-bound mycolic acids. J Gen Microbiol, 1980, 121: 249-253.
  19. Shetty KT, Antia NH and Krishnaswamy PR. Occurrence of - glutamyl transpeptidase activity in several mycobacteria including Mycobacterium leprae. Int J Lepr, 1981, 49: 49-56.
  20. Young DB. Detection of mycobacterial lipids in skin biopsies from leprosy patients. Int J Lep, 1981, 49: 198-204.
  21. Vidyasagar PB, Damle PS. and Antia NH. A study of the sciatic nerve compound action potential In vitro in normal and M. leprae infected mice. Ind J Lepr, 1981, 53: 537-555.
  22. Shetty VP and Antia NH. Degeneration and regeneration of unmyelinated fibres in experimental leprous neuropathy. Int J Lepr, 1981, 49: 324-330.
  23. Khanolkar SR, Ambrose EJ and Mahadevan PR. Uptake of 3, 4-dihydroxy[3H] phenylalanine by Mycobacterium leprae isolated from frozen (-80oC) armadillo tissue. J Gen Microbiol, 1981, 127: 385-389.
  24. Kurup IG and Mahadevan PR. Cholesterol metabolism of macrophages in relation to presence M. leprae. J Biosci, 1982, 4: 307-316.
  25. Lad SJ and Mahadevan PR. Adherence of Mycobacterium leprae to macrophage as an indicator of pathogen induced membrane changes. Ind J Med Res, 1982, 76: 804-881.
  26. Young DB. Mycobacterial lipids in infected tissue samples. Ann Microbiol, 1982, 133: 53-58.
  27. Antia NH. Leprosy: A disease of the Schwann cell. Ind J Lepr, 1982, 54: 599-604.
  28. Antia NH and Kamala N. Persistence of M. leprae in the peripheral nerve. Ind J Med Res, 1983, 77: 420-422.
  29. Mistry NF, Birdi TJ, Mahadevan PR and Antia NH. Macrophage somatic hybrids in leprosy.  Technique standardization and dominance of lepromatous pattern of Fc receptor activity. IRCS Med Sci, 1983, 11: 386-387.
  30. Donde SV, Shah A and Antia NH. Nerve conduction in leprosy: In vivo and in vitro study. Ind J Lepr, 1983, 55: 12-21.
  31. Lad SJ, Salgame PR and Mahadevan PR. Surface membrane changes in lepromatous macrophages affecting the adherence of Mycobacterium leprae. J Biosci, 1983, 5: 131-138.
  32. Salgame PR, Mahadevan PR and Antia NH. Mechanism of immunosuppression in leprosy:  Presence of suppressor factor(s) from macrophages of lepromatous patients. Infect Immun, 1983, 40: 1119-1126.
  33. Salgame PR, Mahadevan PR and Antia NH. Study of concanavalin A receptors on macrophages in leprosy. IRCS Med Sci, 1983, 11: 991-992.
  34. Vithala L, Talati S and Mahadevan PR. An In vitro system to study drug sensitivity of Mycobacterium leprae using infected human tissue.  J Biosci, 1983, 5: 235-241.
  35. Antia NH. Cultivation of M.leprae. Ind J Lepr, 1983, 55: 420-423.
  36. Birdi TJ, Mistry NF, Mahadevan PR. and Antia NH. Alterations in the membrane of macrophages from leprosy patients. Infect Immun, 1983, 41: 121-127.
  37. Birdi TJ and Antia NH. An In vitro method of screening for drug sensitivity. IRCS Med Sci, 1984, 12: 256-257.
  38. Mistry NF, Birdi TJ, Uplekar M and Antia NH. A sequential histopathological study of the lepromin reaction in leprosy patients. IRCS Med Sci, 1984, 12: 287-288.
  39. Birdi TJ, Salgame PR, Mahadevan PR and Antia NH. An indomethacin sensitive suppressor factor released by macrophages of leprosy patients. J. Biosci. 1984, 6: 125-134.
  40. Nair I and Mahadevan PR. An In vitro test using cholesterol metabolism of macrophages to determine drug sensitivity and resistance of Mycobacterium leprae. J Biosci, 1984, 6: 221-231.
  41. Birdi TJ, Mistry NF, Mahadevan PR and Antia NH. In vitro studies on the effect of levamisole in lepromatous leprosy. J Clin Lab Immunol, 1984, 13: 93-96.
  42. Salgame PR, Mahadevan PR and Antia NH. Production of antibody to suppressor factor(s) in macrophages of lepromatous leprosy patients. IRCS Med Sci, 1984, 12: 736-737.
  43. Antia NH and Birdi TJ. An overview on the leprosy vaccine. Ind J Lepr, 1984, 56: 301-306.
  44. Mehta LN and Antia NH. Ultrastructure of sciatic nerve of armadillo infected with Mycobacterium leprae. Ind J Lepr, 1984, 56: 540-554.
  45. Kamala AN, Shetty VP and Antia NH. Evaluation of the neurotoxicity of dapsone in the mouse model. Ind J Lepr, 1984, 56: 251-256.
  46. Mistry NF, Birdi TJ and Antia NH. Suitability of kinetics of macrophage-lymphocyte interaction to distinguish between exposure and susceptibility to M. leprae. IRCS Med Sci, 1984, 12: 839-840.
  47. Khandke L, Penumarti N and Mahadevan PR. Phosphatidylino-sitomannosides in lepromatous leprosy nodules. Ind J Med Res, 1984, 80: 259-263.
  48. Salgame PR, Birdi TJ, Lad SJ, Mahadevan PR and Antia NH. Mechanism of immunosuppression in leprosy – macrophage membrane alterations. J Clin Lab Immunol, 1984, 14: 145-149.
  49. Birdi TJ, Mistry NF, Mahadevan PR, Antia NH. Antigen specific macrophage - lymphocyte interaction in lepromatous leprosy. J Clin Lab Immunol, 1984, 13: 189-194.
  50. Khandke L, Salgame PR, Mahadevan, P.R. In vitro lymphocyte stimulating ability of cell components of Mycobacterium leprae. IRCS Med Sci, 1984, 12: 1012-1013.
  51. Ramasesh N, Bhagaria A, Mahadevan PR. A rapid method for determining the viability of Mycobacterium leprae within macrophages. IRCS Med Sci, 1984, 12: 1014-1015.
  52. Mankar MV, Jagannathan R, Mahadevan PR. In vitro drug screening system using membrane alteration in macrophages by Mycobacterium leprae. J Biosci, 1984, 6: 709-716.
  53. Marolia J, Mahadevan PR. Hydrolytic enzymes in macrophages from leprosy patients in presence of Mycobacterium leprae. Ind J Lepr, 1984, 56: 776-783.
  54. Kamala AN, Antia NH, Shetty, VP. Study of the involvement of the sciatic nerve following inoculation with M. leprae and other mycobacteria in the mouse foot pad. Int J Lepr, 1984, 52: 506-514.
  55. Shetty VP, Antia NH. Multiple axonal myelination in the experimental mouse leprosy model. Int J Lepr, 1984, 52: 249-251.
  56. Jagannathan R, Mahadevan PR. Synergistic activity of dapsone and brodimoprim (a dihydrofolate inhibitor) against Mycobacterium leprae. IRCS Med Sci, 1985, 13: 265-266.
  57. Mukherjee R, Mistry Y, Antia NH, Klein N, Vemuri N. Incorporation of (14C)-acetate into the specific phenolic glycolipid of M.leprae maintained within cultured cells. IRCS Med Sci, 1985, 13: 203-204.
  58. Talati S, Mahadevan PR. Lipase and penicillinase activity in Mycobacterium leprae. IRCS Med Sci, 1985, 13: 290-291.
  59. Mukherjee R, Antia NH. Intracellular multiplication of leprosy-derived Mycobacteria in Schwann cells of dorsal root ganglion cultures. J Clin Microbiol, 1985, 21: 808-814.
  60. Ambrose EJ, Antia NH, Birdi TJ, Mahadevan PR, Mester L, Mistry NF, Mukherjee R, Shetty VP. The action of deoxyfructose serotonin on intracellular bacilli and on host response in leprosy. Lepr Rev, 1985, 56: 199-208.
  61. Shetty VP, Mistry NF, Antia NH. Serum demyelinating factors and adjuvant like activity of Mycobacterium leprae:  Possible cause of early nerve damage in leprosy. Lepr Rev, 1985, 56: 221-227.
  62. Vemuri N, Khandke L, Mahadevan PR, Hunter SW, Brennan PJ. Isolation of phenolic glycolipid I from human lepromatous nodules. Int  J Lepr, 1985, 53: 487-489.
  63. Antia NH, Mukherjee R. Nerve tissue culture:  A useful model for the study of nerve damage in Hansen's disease. The Star, 1985, 45: 8-9.
  64. Mahadevan PR. Host-parasite interaction in relation to leprosy Ind J Lepr 1985, 57: 239-257.
  65. Mistry NF, Birdi TJ, Mahadevan PR, Antia NH. Mycobacterium leprae-induced alterations in macrophage Fc receptor expression and monocyte-lymphocyte interaction in familial contacts of leprosy patients. Scand J Immunol, 1985, 22: 415-423.
  66. Mukherjee R, Antia NH. Adherence of M.leprae to Schwann cells In vitro: a specific phenomenon. IRCS Med Sci, 1985, 13: 853-854.
  67. Antia NH, Barros U, Shetty VP. Demonstration of M. leprae antigens in nerves of tuberculoid patients. Med Sci, 1985, 13: 914-915.
  68. Mukherjee R, Antia NH. Migration and proliferation of Schwann cells in adult human leprous nerve cultures. Lepr Rev, 1985, 56: 321-330.
  69. Antia NH, Mistry NF. Plasma cells in caseous necrosis of nerves in leprosy. Lepr Rev, 1985, 56: 331-335.
  70. Birdi TJ, Salgame PR, Bharucha H, Antia NH. In vitro tests for screening of immunomodulating mycobacterial strains in leprosy. J Biosci, 1986, 10: 127-135.
  71. Jagannathan R, Mahadevan PR. Minimum inhibitory concentration of drugs against Mycobacterium leprae as determined by an In vitro assay. J Biosci, 1986, 10: 137-144.
  72. Irani S, Mukherjee R, Jagannathan R, Antia NH. In vitro study of the effect of dapsone on the components of the peripheral nerve in organised nerve culture model. Ind J Med Res, 1986, 83: 449-452.
  73. Agarwal S, Vemuri N, Mahadevan PR. Macrophage membrane alterations in leprosy as determined by change in sialic acid level. J Clin Lab Immunol, 1986, 19: 119-122.
  74. Mistry NF, Birdi TJ, Antia NH. M. leprae phagocytosis and it's association with membrane changes in macrophages from leprosy patients. Parasite Immunol, 1986, 8: 129-138.
  75. Shetty VP, George V. Xenograft studies in leprous neuropathy. Int J Lepr, 1986, 54: 133-135.
  76. Talati S, Mahadevan PR. Lipase Activity in Mycobacterium leprae - and indicator of metabolic function. Ind J Lepr, 1986, 58: 367-372.
  77. Itty BM, Mukherjee R, Antia NH. Adherence of Mycobacterium leprae to Schwann Cells In vitro. J Med Microbiol, 1986, 22: 277-282.
  78. Uplekar MW, Antia, N.. Clinical and histopathological observations on pure neuritic leprosy. Ind J Lepr, 1986, 58: 513-521.
  79. Mahadevan PR, Jagannathan R, Bhagria A, Vejare S, Agarwal S. Host - pathogen interaction - a new In vitro drug test systems against Mycobacterium leprae - their possibilities and limitations. Lepr Rev, 1986, 57: 182-200.
  80. Uplekar MW, Antia NH. Dapsone dependent nodular panniculitis. Ind J Lepr, 1986, 58: 286-290.
  81. Mukherjee R, Antia NH. Host-parasite interrelationship between M.leprae and Schwann cells in vitro. Int J Lepr, 1986, 54: 632-638.
  82. Birdi TJ, Antia NH. The macrophage defect in leprosy. Proceedings of the Indo-UK symposium on leprosy, Agra. 1986, 68-72.
  83. Mahadevan PR, Jagannathan R, Bhagria A. In vitro drug test systems against M.leprae. Proceedings of the Indo-UK symposium on leprosy, Agra. 1986, 337-350.
  84. Vejare S, Mahadevan PR. Importance of determining viability of Mycobacterium leprae inside macrophages - an In vitro method using uracil. J Biosci, 1987, 11: 455-463.
  85. Bhagaria A, Mahadevan PR. A rapid method for viability and drug sensitivity of Mycobacterium leprae cultured in macrophages and using fluorescein diacetate. Ind J Lepr, 1987, 59: 9-11.
  86. Jacobs JM, Shetty VP, Antia NH. Myelin changes in leprous neuropathy. Acta Neuropathol,1987, 74: 75-80.
  87. Jacobs JM, Shetty VP, Antia NH. Teased fibre studies in leprous neuropathy. J Neurol Sci, 1987, 79: 301-313.
  88. Barros U, Shetty VP, Antia NH. Demonstration of Mycobacterium leprae antigen in nerves of tuberculoid leprosy. Acta Neuropathol, 1987, 73: 387-392.
  89. Marolia J, Mahadevan PR. Superoxide production from macrophages of leprosy patients after stimulation with Mycobacterium leprae. J Biosci, 1987, 12: 273-279.
  90. Barros U, Ladliwala U, Birdi TJ, Antia NH. Localization and retention of mycobacterial antigen in lymph nodes of leprosy patients. Br J Exp Path, 1987, 68: 733-741.
  91. Jagannathan R, Mahadevan PR. Concurrence of the In vitro methods of Fc receptor assay and ATP estimation for viability of Mycobacterium leprae. Med Sci Res, 1987, 15: 1377-1378.
  92. Robinson P, Mahadevan PR. A component of Mycobacterium leprae as immunomodulating agent for immune deficient cells of leprosy patients. J Clin Lab Immunol, 1987, 24: 171-176.
  93. Antia NH, Uplekar MW, Ambrose EJ, Mahadevan PR, Mester L. Effect of Deoxyfructo Serotonin (DFS) on lepromatous Leprosy. The Lancet, 1988, 1: 619-622.
  94. Vermani M, Mahadevan PR. A component of Mycobacterium leprae as immunomodulating agent - Activation of macrophages to contain viability of M. leprae In vivo and In vitro. Quaderni di cooperazione sanitaria - Health cooperation papers. 1988, 7: 153-161.
  95. Hooper M, Bhagaria A, Beveridge EG, Jagannathan R, Mahadevan PR, Yeap SK. The identification of novel tyrosinase inhibitors with In vitro activity against Mycobacterium leprae. Quaderni di cooperazione sanitaria - Health cooperation papers. 1988, 7: 259-270.
  96. Antia NH, Birdi TJ. Leprosy vaccine - a reappraisal (Editorial).   Int J Lepr, 1988, 56: 310-313.
  97. Mehta R, Mukherjee R, Landon D, Verghese G, Antia NH. In vitro interaction of M.leprae-infected Schwann cells and splenic cells. Acta Neuropathol, 1988, 76: 407-410.
  98. Desai S, Birdi TJ, Antia NH. Presence of M.leprae specific lymphocytes in lymph nodes of lepromatous leprosy patients. Scand J Immunol, 1988, 28: 211-216.
  99. Marolia J, Mahadevan PR. Mycobacterium leprae mediated stimulation of macrophages from leprosy patients and hydrogen peroxide production. J Biosci, 1988, 13: 295-303.
  100. Ranade A, Mahadevan PR. A component of Mycobacterium leprae as a serodiagnostic tool for leprosy. Ind J Biochem Biophys, 1988, 25: 554-559.
  101. Jagannathan R, Patil D, Mahadevan PR. Correlation of In vitro Fc receptor assay with In vivo mouse foot pad method. Ind J Lepr, 1988, 60: 517-525.
  102. Shetty VP, Antia NH. Nerve damage in Leprosy. Int    Lepr, 1988, 56: 619-620.
  103. Antia NH, Mistry NF, Kulkarni, VC. Multiplication of armadillo derived M.leprae in murine dissociated Schwann cell cultures. Int J Lepr, 1988, 56: 632-635.
  104. Shetty VP, Jacobs JM, Antia NH. The pathology of early leprous neuropathy. J Neurol Sci, 1988, 88: 115-131.
  105. Mehta R, Birdi TJ, Antia NH. Effect of M. leprae infected Schwann cells and their supernatant on lymphocyte neuroglia interaction. J Neuroimmunol, 1989, 22: 149-156.
  106. Mistry Y, Antia NH, Mukherjee R. Correlation of bacterial viability with uptake of 14C acetate into phenolic glycolipid-1 of Mycobacterium leprae within Schwannoma cells. J Biosci, 1989, 14: 37-45.
  107. Desai S, Birdi TJ, Antia NH. Correlation between macrophage activation, bacterial function and antigen presentation of M. leprae in macrophages of leprosy patients and normal individuals. Infect Immun, 1989, 57: 1311-1317.
  108. Mistry NF, Antia NH. A critique on the interpretation of the lepromin reaction using heat-killed M. leprae vaccine. Int J Lepr, 1989, 57: 110-111.
  109. Marolia J, Mahadevan PR. Reactive oxygen intermediates inactivate Mycobacterium leprae in the phagocytes from human peripheral blood. Int J Lep 1989, 57: 483-491.
  110. Birdi TJ, Antia NH. The macrophage in leprosy: A review on the current status. Int J Lepr, 1989, 57: 511-525.
  111. Choudhury A, Mistry NF, Antia NH. Effects of derivative of serotonin (deoxyfructoserotonin) and other antileprosy drugs on attachment and uptake of Mycobacterium leprae by Schwann cells In vitro.  Antimicrob Agents and Chemother, 1989, 33: 866-870.
  112. Mester De Parajd M, Ambrose EJ, Tayeb N, Antia NH. Deoxyfructoserotonin: Therapuetic effect in treatment of leprosy. Acta Leprologica, 1989, 7: 200-202.
  113. Ghaswala PS, Mistry NF, Antia NH. Serum antibodies of normals and leprosy patients show equal binding to peripheral nerve. Int J Lepr, 1989, 57: 690-692.
  114. Antia NH. Experimental models in leprous neuropathy. (Indo-UK Workshop on Leprosy Research) Lepr Res Rev, Jalma, Agra, 1989, 87-91.
  115. Choudhury A, Mistry NF, Antia NH. Blocking of Mycobacterium leprae adherence to dissociated Schwann cells by anti-mycobacterial antibodies. Scand J Immunol, 1989, 30: 505-509.
  116. Antia NH, Shetty VP, Mukherjee R. Neural lesions in leprosy. Med Res, 1989, 1: 61-86.
  117. Mahadevan PR. Conceptual basis and practical constraints in screening for viability of Mycobacterium leprae. Indo-UK Workshop on Leprosy Research. Jalma, Agra, 1989, 132-134.
  118. Marolia J, Robinson P,  Mahadevan PR. A complex component modulating immune-deficient cells in leprosy patients leading to loss of viability of Mycobacterium leprae - a possible vaccine. Clin Exptl Immunol, 1990, 79: 72-77.
  119. Seydel JK, Wempe EG, Rosenfeld M, Jagannathan R, Mahadevan PR, Dhople AM. In vitro and In vivo experiments with the new inhibitor of Mycobacterium leprae brodimoprim aloue and in combination with dapsone. Arznemittel Forschung (Drug Research), 1990, 40: 69-75.
  120. Shetty KT, Naik PM, Mahadevan PR. A specific colorimetric assay for dapsone in biological fluids. Ind J Clin Biochem, 1990, 5: 101-109.
  121. Nair I, Mahadevan PR. Antigenic protein from Mycobacterium leprae released In vitro as indicator of viability of bacteria. Int J Lep, 1990, 58: 540-547.
  122. Nair I, Varadkar D, Mahadevan PR. Viability of Mycobacterium leprae inside macrophages from different strains of mice and possible genetic control. Int J Lepr, 1990, 58: 548-553.
  123. Mahadevan PR, Robinson P. An antigenic complex that restores ability in leprosy patients to kill Mycobacterium leprae - The probable molecular events identified by In vitro experiments. Trop  Med  Parasitol, 1990, 41: 310-313.
  124. D'Souza S, Mistry NF, Antia NH. Specificity of lymphoid cells within peripheral nerve lesions of paucibacillary leprosy patients. Trop Med Parasitol, 1990, 41: 321-323.
  125. Antia NH. Surgery for Leprosy. (Editorial). Nat Med J India, 1991, 4: 2-4.
  126. Antia NH, Rajwade VA, Das E. Simple methods for disinfecting household drinking water. Nat Med J India, 1991, 4: 218-220.
  127. Antia NH, Daver BM. Surgery for Leprosy. Nat Med J India, 1991, 4: 236-246.
  128. Mistry Y, Antia NH, Mukherjee R. Radiolabelling of Mycobacterium leprae lipids within Schwannoma cells, a potential drug screening system. Antimicrob Agents Chemother, 1991, 35: 1444-1447.
  129. Antia NH, Mistry NF. Dr. Dharmendra's influence in the various fields of leprosy. Ind J Lepr, 1991, 63: 297-300.
  130. Mahadevan PR, Robinson P, Vermani M, Pardhy A, Joshi S. Delipidified cell components of Mycobacterium Leprae and its applications. Ind J Lepr, 1991, 63: 371-387.
  131. Mahadevan PR, Robinson P. Molecular biology of host susceptibility to leprosy in relation to surface properties of macrophages. DAE Symposium on Molecular Biology of Microorganism, National Chemical Laboratory, Pune. 1992, 169-176.
  132. Shetty VP, Mukherjee R, Antia, NH. Ultrastructural study of mouse dorsal root ganglion cultures infected long-term with M. leprae. Ind J Lepr, 1992, 64: 293-301.
  133. Mistry NF, Shetty V, Shetty VP, Antia, NH. Ability and unctional implications of sensitization of lymphoid cells In vitro by mycobacterial infected Schwann cells. Proceedings of International Conference on Neurobiology: Goa India, 1991. In: Nervous Systems: Principles of design and Function. Edited by R. Naresh Singh 1992, 437-450.
  134. Shetty VP, Antia NH. Unusual cells of leprous neuritis: a short communication. Int J Lepr, 1992, 60: 483-485.
  135. Mauron J, Ganapati R, Mahadevan PR, Anantharaman K.  The use of an amino acid as a precursor of a bioactive metabolite in combatting  an  infectious  disease : the  efficacy  of a  tryptophan-enriched diet in the treatment of leprosy. Amino Acids,  1992, 2: 255-269.
  136. Antia NH, Rajawade VA, Das E. Simple methods for disinfecting household drinking water. J Solar Soc India, 1992, 2: 131-137.
  137. Shetty VP, Khade S, Uplekar MW, Antia NH. Persistance of M. leprae in the peripheral nerve as compared to skin of multidrug treated leprosy patients. Lepr Rev, 1993, 63: 329-336.
  138. Joshi S, Nair SC, Mahadevan PR. Antigenic similarity of a cultivable acid fast bacterium to Mycobacterium leprae. Ind J Med Res, 1993, 97: 18-24.
  139. Jacobs JM, Shetty VP, Antia, NH. A morphological study of nerve biopsies from cases of multibacillary leprosy given multidrug therapy. Acta Neuropatho, 1993, 85: 533-541.
  140. Iyer D, Mahadevan PR. Leprosy: Microbiology. Ind J Microbiol, 1993, 33: 1-23.
  141. Mahadevan PR. Mycobacteria and the host. Current Science, 1993, 64: 655-659.
  142. Shetty VP. Animal model to study the mechanism of nerve damage in leprosy: a preliminary report. Int J Lepr, 1993, 61: 70-75.
  143. Mistry NF, Antia NH. Polymerase chain reaction and assessment of leprosy chemotherapy - letter. Lancet, 1993, 342: 1060.
  144. Mistry NF, Murthy S, Sethna KB, Kulkarni VC, Harboe MH, Antia NH. Immunodiagnosis of tuberculosis and leprosy. Nat Med J India, 1993, 6: 297.
  145. Damle A, Mahadevan PR. Nature of peritoneal macrophages from DCC immunized mice. Ind J Lepr, 1993, 65: 405-414.
  146. Antia NH. Keyhole Surgery. The Lancet, 1994, 344: 596-597.
  147. Shetty VP, Uplekar MW, Antia NH. Immunohistochemical localization of mycobacterial antigens within the peripheral nerves of treated leprosy patients and their significance to nerve damage in leprosy. Acta Neuropathol, 1994, 88: 300-306.
  148. Antia NH. Medicine and Ethics - Seventh Shri B.V.Narayana Reddy memorial lecture delivered at Indian Institute of world culture, Bangalore, 1995, 1-16.
  149. Leprosy: Report of a Meeting of physicians and scientists (Antia, N.H., Panel member) at the All India Institute of Medical Sciences, New Delhi. Lancet, 1995, 345: 697-703.
  150. Arolkar SK, Antia NH. Vascular surgery of the posterior tibial compartment for plantar ulceration in leprosy. Lepr Rev, 1995, 66: 48-54.
  151. Shetty VP. Polyaxonal myelination in a human leprous nerve. Int J Lepr, 1995, 63: 104-105.
  152. Save MP, Shetty VP, Antia NH. Intracellular localization of dapsone and rifampicin in skin and nerve of multidrug treated leprosy patients. Ind J Lepr, 1995, 67: 273-284.
  153. Basu A, Mistry NF, Antia NH. Views on the sustenance of resistant Mycobacterium tuberculosis in the environment. Medical Hypotheses, 1995, 45: 421-426.
  154. Mistry NF, Antia NH. Lessons learned from community based preventive health programmes - Implications for early detection of cancer cervix - The FRCH experiment. Paper presented at the workshop conducted by Kidwai Memorial Institute, Bangalore, 1995.
  155. Shetty VP, Mistry NF, Birdi TJ, Antia NH. Effect of T-cell depletion on bacterial multiplication and pattern of nerve damage in M. leprae infected mice. Ind J Lepr, 1995, 67: 363-373.
  156. Antia NH. Overview of leprosy: Four decades of personal observations. The Star, 1995, 54: 8-9.
  157. Birdi TJ, Shetty VP, Antia NH. Differences in M.leprae-induced nerve damage in Swiss white and C57BL/6 mice. Int  J Lepr, 1995, 63: 573-574.
  158. Antia NH. Leprosy. "Surgical diseases in tropical countries" Eds: Suneet Sood and Anurag Krishna, 1996, 76-83.
  159. Vaidya AB, Antia NH. Aspirin history and current relevance. J. NIMA, 1996, 38: 29-33.
  160. Mistry NF, Shetty VP, Antia NH. Nerve tissue culture as an approach towards the study of onset of reaction in the nerve in leprosy - observations and hypothesis. Ind J Lep, 1996, 68: 67-73.
  161. Shetty VP, Antia NH. Animal model for leprous neuropathy: our contribution. Ind, J Lepr, 1996, 68: 95-104.
  162. Shetty VP, Antia NH. A semi quantitative analysis of bacterial load in different cell types in leprous nerves using transmission electron microscope. Ind J Lepr, 1996, 68: 105-108.
  163. Singh N, Birdi TJ, Antia NH. M. leprae infection and macrophage secretory products modulate the expression of NgCAM on Schwann cell surface. Int J Lepr, 1996, 64: 449-451.
  164. Birdi TJ, Desai S, Antia NH. Suppression of lymph node lymphoproliferation to viable M. leprae by peripheral blood derived monocytes. Lepr Rev, 1996, 67: 338-343.
  165. Shetty VP, Uplekar MW, Antia NH. Primary resistance to single and multiple drugs in leprosy: a mouse foot pad study.  Lepr Rev, 1996, 67: 280-286.
  166. Mistry NF, Iyer A, Harboe M, Antia N.H. Low rates of detection of mycobacterial secretory antigen 85 in sera of untreated leprosy patients. Int J Lepr, 1996,  64: 451-452.
  167. Shetty VP, Mistry NF, Uplekar MW, Antia NH, Pai VV, Ganapati R. Dormancy, drug resistance or dependency-some thoughts to ponder. Int J Lepr, 1996, 64: 455-457.
  168. Birdi TJ, D'Souza S, Antia NH. Expression of mycobacterial antigens on murine dissociated Schwann cells infected with viable M.leprae. Microbial Pathogenesis, 1996, 22: 181-185.
  169. Antia NH, Mistry NF. Women in panchayati raj: implications for health for all. In monograph No.1 entitled Taking health to women: Some NGO experiments published by The Institute of Social Studies Trust, New Delhi, 1996, 125-130.
  170. Singh N, Birdi TJ, Antia NH. Nerve growth factor production and expression of p75 by Schwann cells and neurofibroblasts in response to M.leprae infection and macrophage secretory products. Neuropathol. Appl  Neurobiol, 1997, 23: 59-67.
  171. Antia NH, Shetty VP. (Editors). Peripheral nerve in leprosy and other neuropathies. Oxford University Press, Delhi, 1997.
  172. Shetty VP, Suchitra K, Uplekar MW, and Antia NH. Higher incidence of viable M. leprae with in the nerve as compared to skin among multibacillary leprosy patients released from multidrug therapy. Lepr Rev, 1997, 68: 131-138.
  173. Shetty VP, Antia NH. Relapse in a borderline tuberculoid case of leprosy 5 years after the release from rifampicin monotherapy - A case report. Lepr Rev, 1997, 68: 162-166.
  174. Singh N, Birdi TJ, Chandrashekar S, Antia NH. Schwann cell ECM protein production is modulated by M. leprae and macrophage secretory products. J Neurol Sciences, 1997, 151: 13-22.
  175. Antia NH, Uplekar MW. Medicalizing health research to suit the market. (Editorial) Nat Med J India, 1997, 10: 155-157.
  176. Sethna KB, Birdi TJ, Antia, NH. Adherence of Mycobacterium leprae to the nasal mucosa is influenced by surface integrity and viability. J Biosci, 1997, 22: 1-9.
  177. Singh N, Birdi TJ, and Antia, N.H. Differential In vitro modulation of Schwann cell proliferation by Mycobacterium leprae and macrophages in the murine strains, Swiss white and C57BL/6. J. Peripheral Nervous System, 1998, 3: 207-215.
  178. Singh N, Birdi TJ, Antia NH. Collagen profile in sciatic nerves of M. leprae inoculated mice correlates with In vitro collagen production by Schwann cells. Int J Lepr, 1998 , 66: 238-240.
  179. Singh N, Birdi TJ, Chandrashekar S, Antia NH. In vitro studies on extracellular matrix production by M. leprae infected murine neurofibroblasts.  Lepr Rev, 1998, 69: 246-256.
  180. Sethna KB, Mistry NF, Dholakia Y, Antia NH, Harboe M. Longitudinal trends in serum levels of mycobacterial secretory (30 kD) and cytoplasmic (65 kD) antigens during chemotherapy of pulmonary tuberculosis patients. Scand J Infe Dis, 1998, 30: 363-369.
  181. Antia NH, Daver BM, Arora S. Management of burns - Review. Tropical Doctor, 1999, 29: 7-11.
  182. Samant G, Shetty VP, Uplekar MW, Antia NH. Clinical and electrophysiological evaluation of nerve function impairment following cessation of multi drug therapy in leprosy. Lepr Rev, 1999, 70: 10-20.
  183. Antia NH, Daver BM, Arora S. Management of burns: skin cover - Review. Tropical Doctor, 1999,  29: 66-69.
  184. Mistry NF, Antia NH. Incomplete killing of intracellular mycobacteria - Speculations on the creation of persisters. Ind J Lepr, 1999, 71: 69-74.
  185. Shetty VP, Shetty KT, Save MP, Antia N.H. M .leprae induced alteration in the neurofilament phosphorylation leads to demyelination in leprous nerves: A hypothesis. Ind J Lepr, 1999, 71: 121-135.
  186. Shetty VP, Papinder MS, Antia NH. Sciatic nerves of normal and 200 x 5R S/W mice fails to support the multiplication of intranuerally infected M. leprae. Int J Lepr, 1999, 67: 446-452.
  187. Sethna KB, Iyer AM. Comparative leprosy vaccine trial in South India (Letter to the Editor). Ind J Lepr,  1999, 71: 477-78.
  188. Antia NH. Organisation of plastic surgery in developing countries (Gillies Memorial Lecture: 1983). Revisited in Rural Surgery (ARSI Newsletter). 2000, 7: 39-46.
  189. Iyer A, Mistry NF, Antia NH. Clarification to Rada-Schlaefli et al. (Letter to the Editor). Int J Lepr, 2000, 68: 63-64.
  190. Shetty VP, Mistry NF, Antia NH. Current understanding of leprosy as a peripheral nerve disorder: Significance of involvement of peripheral nerve in leprosy. Ind J Lepr, 2000, 72: 339-350.
  191. Antia NH. Science, philosophy and spirituality. Dr. P.Sheel memorial lecture of 22nd January 2000. Gandhi Prasang, Journal published by Basant Behari Jairani Shanti Adhyayan Sansthan, Allahabad. 2000, 3: 41-51.
  192. Mistry NF, Antia NH. Controlling MDR-TB: An agenda beyond drugs In: Health and Equity - Effecting Change. Ed. Shobha Raghuram. HIVOS, Netherlands Technical Report Series 1.8. 2000, 95-102.
  193. Choudhari SK, Indapurkar SC, Mistry NF, Kalyaniwala MD. Maharashtra rural water supply and sanitation project: Health education impact assessment study - A report, 2000.
  194. Daswani PG, Birdi TJ, Antia NH. Study of the action of Cyperus rotundus root decoction on the adherence and enterotoxin production of diarrhoeagenic Escherichia coli. (Letter to the Editor). Ind J Pharmacol, 2001, 33: 116-117.
  195. Shetty VP, Wakade AV, Antia NH, Pai VV, Revankar CR, Ganapati, R, Bulchand HO. Clinical, histopathological and bacteriological investigation in two cases of relapse following ROM treatment. Lepr Rev, 2001, 72: 83-87.
  196. Save MP, Shetty VP. A critique on commentary "How Mycobacterium leprae infects peripheral nerves" by Freedman et al (Letter to the editor). Lepr Rev, 2001, 72: 102-105.
  197. Birdi TJ, Daswani PG, Antarkar DS, Antia NH. Need for bioassays to establish antidiarrhoeal activity of two medicinal plants. Amruth,  2001, 5: 21.
  198. Shetty VP, Wakade AV, Antia NH. A high incidence of viable Mycobacterium leprae in post MDT recurrent lesions in tuberculoid leprosy patients. Lepr Rev, 2001, 72: 337-344.
  199. Shetty VP. Advances in methods of isolation, cultivation and testing of drug susceptibility for Mycobacterium leprae. Dr. Ananthnarayan Memorial Microbiology Symposium on Leprosy - APCON 2001 held at Mumbai on 16 December 2001, 21-32.
  200. Shetty VP, Mistry NF. Key issues related to bacterial persisters (2002), p. 177–186 In Sood OP and Rattan A (ed.) Leprosy Elimination: Critical issues.  Ranbaxy Science Foundation Round Table Conference Series.
  201. Daswani PG, Birdi TJ, Antarkar DS, Antia, NH. Investigation of the antidiarrhoeal activity of Holarrhena antidysenterica. Ind J Pharm Sci, 2002, 64: 164-167.
  202. Shetty, VP, Antia NH. Light and ultrastructural study of sciatic nerve lesions induced using intraneural injection of viable Mycobacterium leprae in normal and immunosuppressed Swiss white mice. Int J Lepr, 2002, 70: 25-36.
  203. Mistry NF, Iyer A, D'Souza D, Taylor GM, Young D, Antia NH. Spoligotyping of Mycobacterium tuberculosis isolates from multiple drug resistant tuberculosis patients from Bombay, India J Clin Microbiol, 2002, 40: 2677-2680.
  204. Birdi TJ, Dholakia Y, D’souza D, Rajgor BA, Hira S, Antia, NH. Antia Preliminary report on initial mycobacterial drug resistance in HIV-TB dual infection in Mumbai. BMJ SA, 2002, 18: 879-881.
  205. Mistry NF, Birdi TJ, Antia NH. Community aspects of diarrhoeal disease control In Diarrhoeal Diseases: Current Status, esearch Trends and Field Studies- Proceedings of  The Third Sir Dorabji Tata Sumposium Raghunath D and Nayak R. (ed.). Tata McGrawHill Publishing CO.Ltd, 2003: 305-311.
  206. Shetty VP, Wakade AV, Ghate S, Pai VV, Ganapati R, Antia, NH. Viability and drug susceptibility testing of M. leprae using mouse foot pad in 37 relapse cases of leprosy. Int J Leprosy, 2003, 71: 210-217.
  207. Mistry NF, Antia NH. Obstacles to the control of MDR-TB in India. Health Admin, 2003, 15: 137-142.
  208. Birdi TJ, Antia NH. Mechanisms involved in peripheral nerve damage in leprosy with special reference to insights obtained from in vitro studies and the experimental mouse model. Int J Leprosy, 2003, 71: 345-353.
  209. D’souza D, Birdi TB, Dholakia Y, Hira S, Antia NH. Importance of blood samples for diagnosis and drug sensitivity testing in HIV positive patients with suspected Tuberculosis. Ind J Tuberculosis, 2004, 51:77-81.
  210. Save MP, Shetty VP, Shetty KT, Antia NH. Part 1: Alterations in neurofilament protein(s) in human leprous nerves: morphology, immunohistochemistry and Western immunoblot correlative study. Neuropathology & Applied Neurobiology, 2004,  30: 635-650.
  211. Atre S, Mistry NF. Partnering for tackling tuberculosis: Strategies and challenges. The Revised National Tuberculosis Control Programme. A community-based alternative for DOTS delivery. Available at http://www.absindia.org/ housekeeping/ learning/uploadedfiles/ Partnering %20for%20tactkling% 20tuberculosis.doc and http://www.abs-india.org/learning/ summary. aspx? RS CAT ID=10, from Dec2004
  212. Atre S.R, Mistry NF. Multidrug- resistant tuberculosis (MDR-TB) in India: An attempt to link biosocial determinants. J Public Health Policy, 2005,  26: 96-114.
  213. Shetty VP, Wakade AV, Ghate SD, Pai VV, Ganpati RR, Antia, NH. Clinical and histopathological and bacteriological study of 52 referral MB cases relapsing after MDT. Lepr Rev, 2005, 76: 241-252.
  214. Wagchaure CK, Tetali P, Gunale VR, Antia NH, Birdi TJ. Sacred groves of Parinche Valley of Pune district of Maharashtra,India and their importance. Anthropology and Medicine, 2005, 13: 56-76.
  215. Pandya SS, Shetty VP. The Neuropathy of Leprosy. An Indian Perspective. Elsevier, 2005.
  216. Mistry NF, Dholakia Y, D’Souza D, Taylor M, Hoffner S, Birdi TJ. Rhodococcus and Mycobacterium Tuberculosis-Masquerade or mixed infection. Int J Tuberc Lung Dis, 2006, 10: 351-353.
  217. Brijesh S, Daswani PG, Tetali P, Antia NH, Birdi TJ. Studies on Dalbergia sissoo (Roxb) leave: Possible mechanism(s) of action in infectious diarrhoea. Indian J Pharmacol, 2006, 38:120-124.
  218. Brijesh S, Daswani PG, Tetali P, Rojatkar SR, Antia NH, Birdi TJ. Studies on Pongamia pinnata (L.)Pierre leaves: Understanding the mechanism(s) of action in infectious diarrhea. J Zhejiang Univ SCIENCE B, 2006, 7: 665-674.
  219. Shetty VP, Wakade AV. Isolation of Mycobacterium leprae from untreated borderlin e tuberculoid, Mid-borderline and indeterminate cases using the mouse food pad technique-A study of 209 cases. Lepr Rev, 2006, 77: 336-370.
  220. Tambe PV, Mistry NF, Antia NH. A longitudinal bacteriological study of drinking water quality in a rural community in western Maharashtra: A potential approach for effecting changes in local drinking water management. Available at India Water Portal Website http://www.indiawaterportal.org/data/datastats/msh.
  221. Birdi TJ, Brijesh S, Daswani PG. Approaches towards the  preclinical testing and standardization of medicinal plants. (Proceedings of South Asian Workshop on Traditional Medicine in Banglore (India) Dec. 13 - 15 2006 Organised by AIFO (Italy). Available at http://www.aifo.it/
  222. Agrawal VP, Shetty VP. Comparison of radiorespirometric Buddemeyer assay with ATP assay and mouse foot pad test in detecting viable Mycobacterium leprae from clinical samples. Indian J Med Microbiol, 2007, 25: 358-363.
  223. Atre SR, D’Souza D, Dholakia Y, Mistry NF. Observations on categorization of new TB Cases: Implications for controlling drug resistance. Int. J. Tuber and Lung Dis, 2007, 11: 1152-1153.
  224. Mistry NF. Dr. Noshir Antia – obituary. Nat Med J India, 2007, 20: 205-207.
  225. Mistry NF, Birdi TJ, Shetty VP. – Dr. N. H. Antia -Obituary. Ind. J. Lepr, 2007, 79:
    249-250
  226. Agrawal VP, Shetty VP. Comparison of the mouse foot pad test with a Buddemeyer type radiorespirometirc assay in detecting viable Mycobacterium leprae in human lesional biopsies. Indian J Dermatol Venerol Leprol, 2007, 73: 384-388.
  227. Daswani PG, Brijesh S, Birdi TJ. Preclinical testing of medicinal plants: advantages and approaches. (In Proceedings of Workshop Approaches towards evaluation of medicinal plants prior to clinical trials held at Pune Novemeber 2006). p.61-76.
  228. Brijesh S, Daswani PG, Birdi TJ. Approaches to Standardization of Medicinal Plant preparations. (In Proceedings of Workshop Approaches towards evaluation of medicinal plants prior to clinical trials held at Pune Novemeber 2006). P.101-114.
  229. Wakade AV, Shetty VP. Effect of cryo preservation on Mycobacterium leprae growth in the foot pads of non immunosuppressed mice.  Lepr Rev, 2007, 78: 381-385.
  230. Shetty VP, Van Brakel WH, Saunderson P, Brandsma JW, Post E, Jellema, Remke, Mcknight, Jason. International workshop on neuropathology in leprosy – consensus report  Lepr Rev, 2007, 78: 416-433.
  231. Tambe PV, Daswani PG, Ghadge A A, Mistry NF, Antia NH. A community-based bacteriological study of drinking water quality and its feedback to a rural community in Western Maharashtra, India. Journal of Health Population and Nutrition, 2008,  26: 139-150.
  232. Khambati FA, Shetty VP, Ghate SD, Pai VV, Ganapati R. Effect of corticosteroid usage on the bacterial killing, clearance and nerve damage in leprosy: A prospective cohort study: Part 1.  Study design and baseline findings in 400 MB cases presenting with and with out reaction.  Lepr Rev, 2008, 79: 134-153.
  233. Shetty VP, Birdi TJ, Mistry NF. Dr. N.H. Antia – obituary.  Lepr Rev, 2008, 79: 199-202.
  234. Shetty VP, Doshi RP. Detection and classification of Leprosy: future needs and Strategies. Indian J Leprosy, 2008, 80:139-147.
  235. Shetty VP, Thakar UH, D’Souza E, Ghate SD, Arora S, Doshi, P, Wakade AV, Thakur D.V. Detection of previously undetected Leprosy cases in a defined Rural and Urban area of Maharashtra, Western India. Lepr Rev, 2009, 80: 22-33.
  236. Khambati FA, Shetty VP, Ghate SD, Capadia GD. Sensitivity and specificity of nerve palpation, monofilament testing and voluntary muscle testing in detecting in peripheral nerve abnormality, using nerve conduction velocity as gold standard: A study in 400 untreated multibacillary leprosy patients. Lepr Rev, 2009, 80: 34-50.
  237. Tetali P, Wagchaure CK, Daswani PG, Antia NH, Birdi TJ. Ethnobotanical Survey of Antidiarrhoeal Plants of Parinche valley, Pune district, Maharashtra, India. J. Ethnopharmacol, 2009, 123: 229-236.
  238. D’souza D, Mistry NF, Vira T, Dholakia Y, Hoffner S, Pasvol G, Nicol M,Wilkinson R. High levels of Multidrug Resistant Tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Programme in an Urban metropolis (Mumbai) in Western India. BMC Public Health, 2009, 9: 211.
  239. Brijesh S, Daswani P, Tetali P, Antia N, Birdi T. Studies on antidiarrhoeal activity of Aegle marmelos unripe fruit: Validating its traditional usage. BMC Complementary and Alternative Medicine, 2009, 9: 47.
  240. Save MP, Shetty VP, Shetty KT.  Hypophosphorylation of NF-H and NF-M subunits of neurofilaments and the associated decrease in KSPXK kinase activity in the sciatic nerves of Swiss White mice inoculated in the foot pad with Mycobacterium leprae.   Lepr Rev, 2009, 80: 388-407.
  241. Shetty VP, Pandya SS, Arora S, Capadia GD. Observations from a ‘Special selective drive’ conducted under National Leprosy Elimination. Programme in Karjat taluka and Gadchiroli district of Maharashtra. Ind J Lepr, 2009, 81: 189-193.
  242. Daswani, PG, Brijish S, Tetali T, Birdi TJ. Anti-diarrhoeal activity of Zingiber officinale (Rosc). Current Sci, 2010, 98: 220-229.
  243. Shetty VP. Patho-mechanisms of Nerve Damage: In IAL Textbook of Leprosy Kar Hemant kumar and Bhushan Kumar, (ed.) Ch19 Jaypee Brothers Medical Publishers (P) Ltd., 2010: pg 237-247.
  244. Gupta UD,  Shetty VP.  Drug   resistance   studies, viability and bacterial persisters and animal models in leprosy: In IAL Text book of Leprosy Kar Hemant Kumar and Bhushan Kumar, (ed.) Ch38, Jaypee   Brothers Medical Publishers (P) Ltd., 2010: Pg 492-502.
  245. Shetty VP. Challenges facing the control of leprosy in Indian context. Annals Academy of Medicine Singapore, 2010: 21-27.
  246. Capadia GD, Shetty VP, Khambati FA, Ghate SD.  Effect of corticosteroid usage along with multi-drug   therapy on   nerve damage assessed  using nerve conduction studies: A  prospective Cohort study of 365 untreated multibacillary (MB) leprosy patients.  Journal of Clinical Neurophysiology, 2010, 27: 38-47.
  247. Shetty VP, Khambati FA, Ghate SD, Capadia GD, Pai VV,  Ganapati R. The effect of corticosteroids usage on the bacterial killing, clearance & nerve damage in Leprosy; Part 3- Study of  two Comparable groups of 100 multibacillary (MB) patients each, treated  with MDT+ steroids versus MDT alone, assessed at 6 months post release from 12 months MB-MDT. Lepr Rev, 2010, 81: 41-58.
  248. Birdi T, Daswani P, S Brijesh, Tetali P, Natu A, Antia, N.  Newer Insights into mechanism of action of Psidium guajava L. leaves in infectious diarrhoea. BMC Complementary and Alternative Medicine, 2010, 10: 33.
  249. Boga P, Shetty VP, Khan Y. Nitric oxide metabolites in sera of patients across the spectrum of leprosy. Ind J Lepr, 2010, 82: 123-129.
  250. Chatterjee A, D'Souza D, Vira T, Bamne A, Ambe GT, Nicol  P, Wilkinson RJ,  Mistry N. Strains of Mycobacterium tuberculosis from Western Maharashtra, India exhibit a high degree of diversity and strain-specific associations with drug resistance, cavitary disease and treatment failure. J Clin Microbiol, 2010, 48: 3593-3599.
  251. Daswani P, Brijesh S, Tetali P, Birdi TJ. Studies on the activity of Cyperus rotundus Linn. tuber against infectious diarrhea. Indian J Pharmacol, 2011, 43: 340-344.
  252. Atre SR, D’Souza D, Vira T, Chatterjee A, Mistry N. Risk factors associated with MDR-TB at the onset of therapy among new cases registered with the RNTCP in Mumbai, India. Indian J. Public Health, 2011, 55: 14-21.
  253. Shetty VP, Wakade AV, Ghate SD, Pai VV. Clinical, Bacteriological and Histopathological   study of 62 referral relapse cases between Jan. 2004 and Dec. 2009 at Foundation for Medical Research, Mumbai. Lepr Rev, 2011, 82: 235-243.
  254. Atre SR, Rangan S, ShettyVP, Giakwad N, Mistry NF.
    Perceptions health seeking behavior and access to diagnosis and treatment initiation among previously undetected leprosy cases in rural Maharashtra, India. Lepr Rev, 2011, 82: 222-234.
  255. Birdi T, Daswani P, S Brijesh, Tetali P. In vitro antigiardial and antirotaviral activity of Psidium guajava L. leaves. Indian J Pharmacol, 2011, 43: 616-617.
  256. S Brijesh, Tetali P, Birdi T. Study of effects of anti- diarrhoeal medicinal plants on entropathogenic Escherichia coli induced interleukin-8 secretion by intestinal epithelial cells. Alternative Medicine studies, 2011, 1: 64-69.
  257. Daswani P, Ghadge A, S Brijesh, Birdi T.  Preparation of decoction of medicinal plants: A self study measure? J Altern Complement Med, 2011, 17:1099-1100.
  258. Dholakia Y, Quazi Z, Mistry N. Drug resistant tuberculosis: Study of clinical practices of chest physicians Maharashtra, India. Lung India, 2011, 29: 30-35.
  259.  
  260. Dholakia YN, D’Souza D, Tolani MP, Chatterjee A, Mistry NF. Chest X-rays and associated clinical parameters in pulmonary Tuberculosis cases from national tuberculosis programme, Mumbai. Infect  Dis Rept, 2012, 4: 30-34.
  261. Bhatter P, Chatterjee A, Mistry N. Mycobacterium tuberculosis Beijing epidemics: A race against mutations. Tuberculosis, 2012, 92: 92-94.
  262. Tolani MP, D’Souza D, Mistry NF. Drug resistance mutation and heteroresistance detected using the Geno Type MTBDR plus assay and their implication for treatment outcomes in patients from Mumbai, India. BMC Infect Dis, 2012, 12: 9.
  263. Kuruwa S, Vissa V, Mistry N. Distribution of Mycobacterium leprae strains among cases in rural and urban population of Maharashtra, India. J Clin Microbiol, 2012, 50: 1406-1411.
  264. Bhatter P, Chatterjee A, D’Souza D, Tolani MP, Mistry NF. Estimating strains fitness by competition assays between drug susceptible and resistance Mycobacterium tuberculosis of predominant Lineages in Mumbai, India. PLoS one, 2012, 7:  e33507.
  265. Shetty VP, Pandaya SS. One year follow up of a cohort of suspected leprosy cases: Finding from a leprosy ‘Selective Special Drive’ in Gadchiroli District, Maharashtra, India. Lepr Rev, 2012, 83: 64-70.
  266. Bhatter P, Chatterjee A, Mistry NF. The dragon and the tiger: Realities in the control of Tuberculosis.  Interdisci. prosp on Infec Diseases, 2012, 2012: 1-10.
  267. Mistry NF, Tolani MP, Osrin D. Drug resistant tuberculosis in Mumbai, India: An agenda for operations research. Operations Research for healthcare, 2012, 1: 45-53.
  268. Birdi T,   D’Souza  D, Tolani M,  Daswani P,   Nair V,  Tetali P, Toro JC,   Hoffner S. Assessment  of   the  activity  of  selected  Indian  medicinal   plants against Mycobacterium  tuberculosis :  A preliminary  screening using  the  Microplate Aalmar  Blue  Assay.  Eur J Med Plants, 2012, 2: 308-323.
  269. Chatterjee A, Mistry NF. MIRU- VNTR profiles of three major Mycobacterium tuberculosis spoligotypes found in Western India. Tuberculosis, 2013; 93: 250-256.
  270. Chatterjee A, Saranath D, Bhatter P, Mistry NF. Global transcriptional profiling of longitudinal clinical isolates of Mycobacterium tuberculosis exhibiting rapid accumulation of drug resistance. PLOS ONE, 2013, 8: e54717.
  271. Shetty VP, Mistry NF, Wakade AV, Ghate SD,  Capadia GD, Pai VV. BCG immunotherapy as an adjuct  to chemotherapy in BL-LL patients-its effects on clinical regression, reaction, severity, nerve function, lepromin conversion, bacterial /antigen clearance and ‘persister’ M. leprae . Lepr Rev, 2013, 84: 23-40.
  272. Shetty VP, Ghate SD, Wakade AV, Thakar DV, D’Souza D. Clinical bacteriological and histopathological characteristics of newly detected children with leprosy: A population based study in a defined rural and urban area of Maharashtra, Western India. I J D V I, 2013, 79: 512-517.
  273. Bhatter P and Mistry NF. Fitness of acquired drug resistant M. tuberculosis isolates from DOTS compliant patients. Tuberculosis, 2013, 93: 418-424.
  274. Lockwood D NJ, Shetty VP, Penna OP. Hazards of setting targets to eliminate disease: lessons from the leprosy elimination campaign. BMJ, 2014, 348: g1136.
  275. Gupta P, Bhatter P, D’Souza D, Tolani MP, Daswani P,  Tetali P,  Birdi T. Evaluating the anti Mycobacterium tuberculosis activity of Alpinia galangal (L.) Wild. Axenically under reducing oxygen conditions and intracellular assays. BMC complimentary & Alternative Medicine, 2014, 14: 84.
  276. Birdi T, S Brijesh, Daswani P. Bactericidal effect of selected antidiarrhoeal medicinal plants on intracellular heat-stable enterotoxin–producing Escherichia coli. Indian Journal of Pharmaceutical sciences, 2014, 79: 229-235.
  277. Gupta P, Daswani P, Birdi T. Approaches in fostering quality parameters in medicinal botanicals in Indian context. Indian Journal of Pharmacology, 2014, 46: 363-371.
  278. Birdi T, Joshi S, Kotian S , Shah S. Possible causes of malnutrition in Melghat, a tribal region of  Maharashtra, India. Global Journal of Health Science, 2014, 6: 164-173.
  279. Bhatter P, Chatterjee A, Mistry NF. Kinetics of recA and recX induction in drug susceptible and MDR clinical strains of Mycobacterium tuberculosis. J. Antimicrob. Chemother, 2014, 69: 3199-202.
  280. Gupta P and Birdi T. Psidium guajava  leaf  extracts  prevent  intestinal colonization of citrobacter rodentium in the mouse model. Journal of Ayurveda and Integrative Medicine, 2015, 6: 50-52.
  281. Bhatter P, Gupta P, Daswani P, Tetali P, Birdi T. Anti mycobacterial efficacy of Andrographis  paniculata  Nees. leaf extracts under intracellular and hypoxic conditions.  J. Evid. Based Complementary Altern Med, 2015, 20:3-8.
  282. Mistry N, Tolani M, Dholakia Y. New drugs for tuberculosis. Drugs of the future, 2015, 40: 39-56 Review.
  283. Gupta PD. Pharmacokinetics, pharmacogenomics and ayurgenomics for personalized medicine: A paradigm shift. Indian J. Pharm.Sci. , 2015, 77: 135-141.
  284. Shetty  VP,        Khodke  AS.    Erythima   Nodosum  leprosum  (ENL)-  like clinical  presentation  of enhanced   histological cell-mediated   immunity (CMI) in treated BL leprosy: A case report. Lepr. Rev, 2015. In Press.
  285. Birdi T , Shah S. Implementing perennial kitchen garden model to improve diet diversity in Melghat, India. Global  Journal of Health Sciences , 2015. In Press.
  286. Dias A , Dhawde   R, Surve N, Weinberg A, Birdi T, Mistry N.  Impact of  climate changes on water availability and quality in the state of Maharashtra in Western India. AJMBES. ,2015, In Press.

© 2015 Foundation for Medical Research | Contact Us

Site Design Mihika Shilpi